Adaptation of the QT interval to heart rate changes in isolated perfused guinea pig heart: Influence of amiodarone and D-SOTALOL

Pharmacological Research

Volumn 35, Issue 5, 1997, Pages 409-416

  Padrini, Roberto ^a   Speranza, Giorgio ^b   Nollo, Giandomenico ^b   Bova, Sergio ^a   Piovan, Donatella ^a   Antolini, Renzo ^b   Ferrari, Mariano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

Author keywords

Amiodarone; D sotalol; Electrical restitution; Heart rate; QT adaptation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EPICARDIUM; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART RATE; HEART RATE VARIABILITY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED HEART; LONG QT SYNDROME; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; TACHYCARDIA; TORSADE DES POINTES;

EID: 0031148913     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0152     Document Type: Article

References (36)

1. Boyett MR, Jewell BR. A study of the factors responsible for rate-dependent shortening of the action potential in mammalian ventricular muscle. J Physiol. 285:1978;359-380.
2. Attwell D, Cohen I, Einser DA. The effects of heart rate on the action potential of guinea-pig and human ventricular muscle. J Physiol. 313:1981;439-461.
3. Drake AJ, Noble MIM, Schouten V, Seed A, Ter Keurs HEDJ, Wohlfart B. Is action potential duration of the intact dog heart related to contractility or stimulus rate? J Physiol. 331:1982;499-510.
4. Elharrar V, Surawicz B. Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol. 244:1983;H782-H792.
5. Boyett MR, Fedida D. Changes in the electrical activity of dog cardiac Purkinje fibres at high heart rates. J Physiol. 350:1984;361-391.
6. c. Br Heart J. 57:1987;32-37.
7. Lau CP, Freedman AR, Fleming S, Malik M, Camm J, Ward DE. Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rates. Cardiovasc Res. 22:1988;67-72.
8. Kuo CS, Amlie JP, Munakata K, Reddy P, Surawicz B. Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res. 17:1983;152-161.
9. Kuo CS, Munakata K, Reddy P, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmias dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367.
10. Weintraub RG, Gow RM, Wilkinson JL. The congenital long QT syndromes in childhood. J Am Coll Cardiol. 16:1990;674-680.
11. c. Am J Cardiol. 68:1991;498-503.
12. Kadish AH, Wiesman HF, Veltri EP, Epstein AE, Slepian MJ, Levine JH. Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents. Circulation. 81:1990;14-19.
13. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Progr Cardiovasc Dis. 31:1988;115-172.
14. Bova S, Padrini R, Cargnelli G, Piovan D, Ferrari M. The influence of acidosis on myocardial uptake and electrocardiographic effects of disopyramide. Eur J Pharmacol. 168:1989;179-185.
15. Padrini R, Bova S, Cargnelli G, Piovan D, Ferrari M. Effects of pinacidil on isolated perfused guinea pig heart with particular reference to the proarrhythmic effect. Br J Pharmacol. 105:1992;715-719.
16. Lambert C, Cardinal R, Vermeulen M, Lamontagne D, Nadeau R, Paradis P, Rouleau JL. Lack of relation between the ventricular refractory period prolongation by amiodarone and the thyroid state in rats. J Pharmacol Exp Ther. 242:1987;320-325.
17. Nollo G, Speranza G, Grasso R, Bonamini R, Antolini R. Dynamic measurement of the QT interval. J Electrocardiol. 25:1992;9-17.
18. Marquardt DW. An algorithm for least squares estimation of non linear parameters. J Soc Ind Appl Math. 2:1963;431-441.
19. Elharrar V, Atarashi H, Surawicz B. Cycle length-dependent action potential duration in canine cardiac Purkinje fibers. Am J Physiol. 247:1984;H936-H945.
20. Zaza A, Malfatto G, Schwartz PJ. Sympathetic modulation of the relation between ventricular repolarization and cycle length. Circ Res. 68:1991;1191-1203.
21. Robinson RB, Boyden PA, Hoffman BF, Hewett KW. Electrical restitution process in dispersed canine cardiac Purkinje and ventricular cells. Am J Physiol. 253:1987;H1018-H1025.
22. Gettes LS, Reuter H. Slow recovery from inactivation of inward currents in mammalian myocardial fibres. J Physiol. 240:1974;703-724.
23. Varrò A, Papp JG. The impact of single cell voltage clamp on understanding of the cardiac ventricular action potential. Cardioscience. 3:1992;131-144.
24. Torres-Arraut E, Singh S, Pichoff AS. Electrophysiological effects of Tween 80 in the myocardium and specialized conduction system of the canine heart. J Electrocardiol. 17:1984;145-152.
25. Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation. 81:1990;686-690.
26. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new antianginal drug, on cardiac muscle. Br J Pharmacol. 39:1970;657-667.
27. Rosenheck S, Schmaltz S, Kadish AH, Summitt J, Morady F. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate. Am Heart J. 121:1991;512-517.
28. Varro A, Elharrar V, Surawicz B. Effect of antiarrhythmic drugs on the premature action potential duration in canine Purkinje fibers. J Pharmacol Exp Ther. 233:1985;304-311.
29. Nattel S, Zeng FD. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje Fibers. J Pharmacol Exp Ther. 229:1984;283-291.
30. Colatsky TJ, Hogan PM. Effects of external calcium, calcium channel-blocking agents, and stimulation frequency on cycle length-dependent changes in canine cardiac action potential duration. Circ Res. 46:1980;543-552.
31. Singh BN, Sarma JSM, Zhang ZH, Takanaka C. Controlling cardiac arrhythmias by lengthening repolarization: rationale from experimental finding and clinical considerations. Ann N Y Acad Sci. 644:1992;187-209.
32. Singh BN. When is QT prolongation antiarrhythmic and is it proarrhythmic? Am J Cardiol. 63:1989;867-869.
33. Mayuga RD, Singer DH. Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies. Cardiovasc Res. 26:1992;571-579.
34. Day CP, McComb JM, Matthews J, Campbell EWF. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J. 12:1991;423-427.
35. Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res. 82:1984;277-285.
36. Takanaka C, Singh BN. Barium-induced non-driven action potentials as a model of triggered automaticity and early afterdepolarizations: Differing effects of amiodarone, and quinidine and significance of slow channel activity. J Am Coll Cardiol. 15:1990;213-221.